Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome
February 2017
in “Journal of the Formosan Medical Association”
TLDR Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.
The study evaluated the effects of metformin on 114 Taiwanese women with polycystic ovary syndrome (PCOS), focusing on insulin resistance (IR) and body mass index (BMI). Metformin significantly improved BMI in overweight patients and reduced 2-hour insulin levels, with greater improvement observed in IR patients. Diagnostic measures for IR showed varying sensitivity and specificity, with the 2-hour postload insulin level being proposed as a convenient screening tool. The study also noted that extended-release (XR) metformin may improve treatment adherence. The results suggest that metformin is effective for improving IR and BMI in overweight and IR Taiwanese women with PCOS, and the 2-hour postload insulin level from an oral glucose tolerance test (OGTT) could be a practical method for IR screening in this population. However, the study had limitations, including the absence of a comparison group, and further research is needed to confirm these findings in different populations and establish a specific cutoff for diagnosing IR in PCOS women.
View this study on doi.org →
Cited in this study
research The Utility of Metformin Therapy in Reproductive-Aged Women with Polycystic Ovary Syndrome (PCOS)
Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.
research Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.
research Epidemiology, diagnosis, and management of polycystic ovary syndrome
PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.
research Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.
research Prevalence of polycystic ovary syndrome in women in China: a large community-based study
PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.
research Polycystic Ovarian Syndrome in Taiwanese Women
Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.
research Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.
research Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.
Related
research Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome
Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.